Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteinases and inhibitors

T E Cawston1

  • 1Rheumatology Research Unit, Addenbrookes Hospital, Cambridge, UK.

British Medical Bulletin
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Proteinases degrade cartilage and bone in joint diseases. Proteinase inhibitors show promise in preventing cartilage destruction and may offer a new therapeutic approach for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A computer simulation approach to assessing therapeutic intervention points for the prevention of cytokine-induced cartilage breakdown.

Arthritis & rheumatology (Hoboken, N.J.)·2014
Same author

Differential Toll-like receptor-dependent collagenase expression in chondrocytes.

Annals of the rheumatic diseases·2008
Same author

Gingival fibroblasts grown from cyclosporin-treated patients show a reduced production of matrix metalloproteinase-1 (MMP-1) compared with normal gingival fibroblasts, and cyclosporin down-regulates the production of MMP-1 stimulated by pro-inflammatory cytokines.

Journal of periodontal research·2007
Same author

Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis.

Arthritis and rheumatism·2006
Same author

Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.

Rheumatology (Oxford, England)·2006
Same author

Development of a novel 2D proteomics approach for the identification of proteins secreted by primary chondrocytes after stimulation by IL-1 and oncostatin M.

Rheumatology (Oxford, England)·2006
Same journal

Augmentation in Achilles tendon repair: evidence versus enthusiasm.

British medical bulletin·2026
Same journal

Regional musculoskeletal pain in workers-is the traditional medical model increasing disability?

British medical bulletin·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
See all related articles

Area of Science:

  • Biochemistry
  • Pathology
  • Pharmacology

Background:

  • Joint diseases involve cartilage and bone destruction.
  • Proteinases, including matrix metalloproteinases (MMPs), are key agents in this degradation.
  • Current treatments do not address the underlying disease mechanisms effectively.

Purpose of the Study:

  • To explore the role of proteinases in joint disease pathology.
  • To investigate proteinase inhibitors as a novel therapeutic strategy.
  • To evaluate the efficacy of proteinase inhibitors in preclinical models.

Main Methods:

  • Review of proteolytic enzymes involved in connective tissue turnover and joint disease.
  • Focus on matrix metalloproteinases (MMPs) and their role.
  • Analysis of existing research on proteinase inhibitors and their mechanisms.

Related Experiment Videos

Main Results:

  • All four classes of proteolytic enzymes contribute to connective tissue pathology.
  • MMPs are significantly implicated in joint disease processes.
  • Proteinase inhibitors have demonstrated efficacy in preventing cartilage destruction in animal models.

Conclusions:

  • Proteinase inhibitors represent a promising therapeutic avenue for joint diseases.
  • Further in vivo studies and patient trials are warranted to confirm effectiveness.
  • Targeting proteinases offers a potential strategy to halt pathological destruction.